Domperidone made prescription-only in MHRA ruling

Domperidone for nausea and vomiting is now available only on prescription, after the MHRA ruled that patients must first be checked for their risk of cardiac side-effects before taking the drug.

Domperidone will now only be available on prescription (Photo: Jason Heath Lancy)
Domperidone will now only be available on prescription (Photo: Jason Heath Lancy)

In April, the MHRA said GPs should no longer prescribe domperidone for bloating or heartburn, following a review by the European Medicines Agency that found a small increased risk of serious cardiac adverse drug reactions relating to its use.

The announcement means patients can now acquire domperidone (Motilium), previously available OTC, only with a prescription from their doctor.

The Commission on Human Medicines, which advises the MHRA, said because pharmacists do not routinely have access to full medical histories, they would be unable quickly and accurately to assess which patients were at risk of cardiac side-effects.

Dr Sarah Branch, deputy director of the MHRA’s Vigilance and Risk Management of Medicines Division, said patients taking domperidone without a prescription who wished to continue were advised to speak to their GP or pharmacist.

She said: 'People who have been prescribed domperidone from their doctor should continue to take their medicine as instructed, as their medical history and any tests will have been assessed before they are given this medicine.

'That is why we have changed this medicine to prescription-only, so that patients can be assessed for any underlying medical conditions that may affect their suitability for domperidone. It should only be used in the relief of symptoms of nausea and vomiting, and at the lowest effective dose for the shortest possible duration.'

Around 45,000 patients were prescribed domperidone in 2012.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Medico-legal: Intimate examinations and chaperones during COVID-19

Medico-legal: Intimate examinations and chaperones during COVID-19

Remote consultations are likely to be a key part of general practice for months to...

NHS England promises detail on additional flu funding ‘by end of August’

NHS England promises detail on additional flu funding ‘by end of August’

GPs may have to wait until the end of August to find out details of any additional...

Why 63% of GPs expect to do more home-working after COVID-19

Why 63% of GPs expect to do more home-working after COVID-19

Working from home was one of the key issues raised in GPonline's survey of more than...

Lack of support during the menopause leading female doctors to quit

Lack of support during the menopause leading female doctors to quit

A lack of support during the menopause has led some female doctors to consider reducing...

One in three single-handed GPs at high-risk from COVID-19

One in three single-handed GPs at high-risk from COVID-19

A third of single-handed GPs are at high-risk from COVID-19, which could potentially...

Viewpoint: PCNs can be at the forefront of tackling health inequalities

Viewpoint: PCNs can be at the forefront of tackling health inequalities

Dr Mark Spencer explains how the COVID-19 pandemic helped his primary care network...